The US Food and Drug Administration on Monday approved the use of the experimental drug aducanumab for early phases of Alzheimer's disease -- despite an FDA advisory committee concluding last year ...

PHILADELPHIA (WPVI) -- The Food & Drug Administration has approved a new drug for Alzheimer's Disease. It's the first in nearly twenty years but it comes with controversy and some experts advised ...

In a new study, scientists discovered two FDA-approved cancer drugs that could also be effective at combatting one well-known ...

If you have a loved one with Alzheimer’s disease, you may have read about a newly approved drug. And you may have heard that the drug has caused some controversy. So, what’s really going on? In early ...

Eli Lilly and Company LLY announced that the European Commission (EC) has granted marketing authorization to Kisunla (donanemab) for the treatment of early symptomatic Alzheimer's disease (AD).

The treatment, lecanemab, has already been approved in some other countries, including the U.S., the U.K., Japan, Mexico and ...

A new study is reviving hope that a twice-daily pill can slow down Alzheimer's in people whose genes put them at high risk ...

Lecanemab, also known by the brand name Leqembi, is approved to treat mild cognitive impairment and early stages of Alzheimer's disease. Patients must have a documented presence of amyloid plaque in ...

The roadmap to fighting Alzheimer’s disease is a matter of updating government policy to match the current science.

Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about ...